These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 1471455)

  • 1. Effects of metyrapone infusion on corticotropin-releasing factor and arginine vasopressin secretion into the hypophysial portal blood of conscious, unrestrained rams.
    Conte-Devolx B; Guillaume V; Boudouresque F; Graziani N; Magnan E; Grino M; Emperaire N; Nahoul K; Cataldi M; Oliver C
    Acta Endocrinol (Copenh); 1992 Nov; 127(5):435-40. PubMed ID: 1471455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Secretion of corticotropin releasing factor (CRF) and vasopressin (AVP) into the hypophysial portal blood of conscious, unrestrained rams.
    Caraty A; Grino M; Locatelli A; Oliver C
    Biochem Biophys Res Commun; 1988 Sep; 155(2):841-9. PubMed ID: 3048263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies of the secretion of corticotropin-releasing factor and arginine vasopressin into the hypophysial-portal circulation of the conscious sheep. I. Effect of an audiovisual stimulus and insulin-induced hypoglycemia.
    Engler D; Pham T; Fullerton MJ; Ooi G; Funder JW; Clarke IJ
    Neuroendocrinology; 1989 Apr; 49(4):367-81. PubMed ID: 2541360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin-induced hypoglycemia stimulates corticotropin-releasing factor and arginine vasopressin secretion into hypophysial portal blood of conscious, unrestrained rams.
    Caraty A; Grino M; Locatelli A; Guillaume V; Boudouresque F; Conte-Devolx B; Oliver C
    J Clin Invest; 1990 Jun; 85(6):1716-21. PubMed ID: 2161426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypophysial-portal plasma levels, median eminence content, and immunohistochemical staining of corticotropin-releasing factor, arginine vasopressin, and oxytocin after pharmacological adrenalectomy.
    Plotsky PM; Sawchenko PE
    Endocrinology; 1987 Apr; 120(4):1361-9. PubMed ID: 3030697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The acute effect of lowering plasma cortisol on the secretion of corticotropin-releasing hormone, arginine vasopressin, and adrenocorticotropin as revealed by intensive sampling of pituitary venous blood in the normal horse.
    Alexander SL; Irvine CH; Livesey JH; Donald RA
    Endocrinology; 1993 Aug; 133(2):860-6. PubMed ID: 8393777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Corticotropin-releasing factor alone, but not arginine vasopressin alone, stimulates the release of adrenocorticotropin in the conscious intact sheep.
    McFarlane A; Coghlan J; Tresham J; Wintour EM
    Endocrinology; 1995 May; 136(5):1821-7. PubMed ID: 7720626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of acute exercise on the secretion of corticotropin-releasing factor, arginine vasopressin, and adrenocorticotropin as measured in pituitary venous blood from the horse.
    Alexander SL; Irvine CH; Ellis MJ; Donald RA
    Endocrinology; 1991 Jan; 128(1):65-72. PubMed ID: 1846116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metyrapone induced increase in plasma corticotropin is not associated with changes in peripheral venous arginine vasopressin or corticotropin releasing factor.
    Holmes SJ; Florkowski CM; Evans MJ; Ellis MJ; Livesey JH; Donald RA; Espiner EA
    J Endocrinol Invest; 1993 Nov; 16(10):787-92. PubMed ID: 8144852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cortisol feedback in adrenalectomized adult sheep.
    McFarlane A; Coghlan J; Tresham J; Wintour EM
    Am J Physiol; 1995 Jul; 269(1 Pt 1):E10-7. PubMed ID: 7631764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of cortisol, vasopressin (AVP), and corticotropin-releasing factor administration on pulsatile adrenocorticotropin, alpha-melanocyte-stimulating hormone, and AVP secretion in the pituitary venous effluent of the horse.
    Livesey JH; Donald RA; Irvine CH; Redekopp C; Alexander SL
    Endocrinology; 1988 Aug; 123(2):713-20. PubMed ID: 2840266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of corticosterone on the secretion of corticotrophin-releasing factor, arginine vasopressin and oxytocin into hypophysial portal blood in long-term hypophysectomized rats.
    Sheward WJ; Fink G
    J Endocrinol; 1991 Apr; 129(1):91-8. PubMed ID: 2030334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Corticotrophin-releasing peptides in rat hypophysial portal blood after paraventricular lesions: a marked reduction in the concentration of corticotrophin-releasing factor-41, but no change in vasopressin.
    Antoni FA; Fink G; Sheward WJ
    J Endocrinol; 1990 May; 125(2):175-83. PubMed ID: 2373973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of the seasonal cycle of beta-endorphin and ACTH secretion into the peripheral blood of rams.
    Ssewannyana E; Lincoln GA; Linton EA; Lowry PJ
    J Endocrinol; 1990 Mar; 124(3):443-54. PubMed ID: 2159047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Marked changes of arginine vasopressin, oxytocin, and corticotropin-releasing hormone in hypophysial portal plasma after pituitary stalk damage in the rat.
    Makara GB; Sutton S; Otto S; Plotsky PM
    Endocrinology; 1995 May; 136(5):1864-8. PubMed ID: 7720631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of adrenalectomy and glucocorticoids on the peptides CRF-41, AVP and oxytocin in rat hypophysial portal blood.
    Fink G; Robinson IC; Tannahill LA
    J Physiol; 1988 Jul; 401():329-45. PubMed ID: 2845063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Luteinizing hormone secretion and corticotropin-releasing factor gene expression in the paraventricular nucleus of rhesus monkeys following cortisol synthesis inhibition.
    Van Vugt DA; Piercy J; Farley AE; Reid RL; Rivest S
    Endocrinology; 1997 Jun; 138(6):2249-58. PubMed ID: 9165008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies of the secretion of corticotropin-releasing factor and arginine vasopressin into the hypophysial-portal circulation of the conscious sheep. II. The central noradrenergic and neuropeptide Y pathways cause immediate and prolonged hypothalamic-pituitary-adrenal activation. Potential involvement in the pseudo-Cushing's syndrome of endogenous depression and anorexia nervosa.
    Liu JP; Clarke IJ; Funder JW; Engler D
    J Clin Invest; 1994 Apr; 93(4):1439-50. PubMed ID: 8163648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of immunoreactive corticotropin-releasing factor secretion into the hypophysial-portal circulation by delayed glucocorticoid feedback.
    Plotsky PM; Otto S; Sapolsky RM
    Endocrinology; 1986 Sep; 119(3):1126-30. PubMed ID: 3015567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Central modulation of immunoreactive arginine vasopressin and oxytocin secretion into the hypophysial-portal circulation by corticotropin-releasing factor.
    Plotsky PM; Bruhn TO; Otto S
    Endocrinology; 1985 Apr; 116(4):1669-71. PubMed ID: 3871693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.